Results 211 to 220 of about 155,600 (259)

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Portable Multichannel Measurement System for Real-Time Microplastics Assessment Using Microwave Sensors. [PDF]

Sensors (Basel)
Barrancos A, Rosinha D, Assis J, Rosado LS.   +3 more
europepmc   +1 more source

The SNAP near infrared detectors

, 2002
Tarle, G., Akerlof, C., Aldering, G., Amanullah, R., Astier, P., Barrelet, E., Bebek, C., Bergstrom, L., Bercovitz, J., Bernstein, G., Bester, M., Bonissent, A., Bower, C., Carithers, W., Commins, E.D., Day, C., Deustua, S., DiGennaro, R., Ealet, Anne, Ellis, R.S., Eriksson, M., Fruchter, A., Genat, J.-F., Goldhaber, G., Goobar, A., Groom, D., Harris, S., Harvey, P., Heetderks, H., Holland, S., Huterer, D., Karcher, A., Kim, A., Kolbe, W., Krieger, B., Lafever, R., Lamoureux, J., Lampton, M., Levi, M.E., Levin, D., Linder, E., Loken, S., Malina, R., Massey, R., Miguel, R., McKay, T., McKee, S., Mortsell, E., Mostek, N., Mufson, S., Musser, J., Nugent, P., Oluseyi, H., Pain, R., Palaio, N., Pankow, D., Perlmutter, S., Pratt, R., Prieto, E., Refregier, A., Rhodes, J., Robinson, K., Roe, N., Sholl, M., Schubnell, M., Smadja, G., Smoot, G., Spadafora, A., Tomasch, A., von der Lippe, H., Vincent, R., Walder, J., Wang, G.   +72 more
openaire   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Towards accurate penetration depth estimation in near-infrared spectroscopy: a quantitative analysis of source-detector distance dependence in porcine kidney models. [PDF]

Biomed Opt Express
Khurana AS, Khodavandi A, Amani Tehrani I, Shadgan B.   +3 more
europepmc   +1 more source

A compact two-electrode field-emission X-ray source for soft X-ray spectroscopy applications. [PDF]

J Synchrotron Radiat
Li J, Wang Y, Yu P, Meng J, Weng T.
europepmc   +1 more source

Extending the depth range in energy-dispersive X-ray stress analysis by simultaneous multi-detector data acquisition in equatorial scattering geometry. [PDF]

J Appl Crystallogr
Genzel C, Apel D, Boin M, Klaus M.
europepmc   +1 more source

Surface-based image reconstruction optimization for high-density functional near-infrared spectroscopy. [PDF]

Neurophotonics
Carlton LB, Altınkaynak M, Kelley SM, Zimmermann BB, Kura S, Middell E, von Lühmann A, Stephen EP, Yücel MA, Boas DA.   +9 more
europepmc   +1 more source